← Back to medicines
Medicine Image
Rx

Pires-M (100 mg+1.1 mg+14 mg)/5 ml

Navana Pharmaceuticals Ltd. · Syrup

Generic

Guaifenesin + Levomenthol + Diphenhydramine

Strength(100 mg+1.1 mg+14 mg)/5 ml
Unit Price
85

/ 100 ml bottle

Order Now

Medicine Description

Detailed scientific information regarding the indications, dosage, potential side effects, and guidelines for use during pregnancy of Pires-M or the Guaifenesin + Levomenthol + Diphenhydramine group is provided below. Always consult a specialist physician before taking any medication.

INDICATIONS

This syrup is indicated for the relief of cough, associated congestive symptoms and aiding restful sleep.


PHARMACOLOGY

Guaifenesin is reported to reduce the viscosity of tenacious sputum end is used as an expectorant. Levomenthol has mild local anesthetic and decongestant properties. Diphenhydramine Hydrochloride possesses antitussive, antihistaminic, and anticholinergic properties.


DOSAGE & ADMINISTRATION

For adults and children over 12 years: 2 teaspoonfuls syrup 4 times a day or as directed by the physicians. Do not take more than 8 teaspoonful syrup in 24 hours.Use in Children & Adolescents: The efficacy and safety of Guaifenesin have not been established in pediatric patients and adolescents.


INTERACTION

This syrup contains Diphenhydramine Hydrochloride and therefore may potentiate the effects of alcohol, and other CNS depressants. As Diphenhydramine Hydrochloride possess some anticholinergic activity, the effects of anticholinergics (e.g. some psychotrophic drugs and atropine) may be potentiated by this product. This may result in tachycardia, mouth dryness, gastrointestinal disturbances (e.g. colic), urinary retention and headache.


SIDE EFFECTS

This syrup may cause drowsiness, dizziness, nausea and vomiting, gastro-intestinal disturbance, dry mouth, nose and throat difficulty in urination or blurred vision.


PREGNANCY & LACTATION

As with any other medicine, care should be taken In administration during pregnancy. This product has not been associated with adverse effects in the human fetus or suckling infant.


PRECAUTIONS & WARNINGS

This syrup may cause drowsiness; if affected, individuals should not drive or operate machinery. Diphenhydramine Hydrochloride should not be taken by individuals with narrow-angle glaucoma or symptomatic prostatic hypertrophy. This product should not be used for persistent or chronic cough, such as occurs with asthma, or where cough is accompanied by excessive secretions unless directed by a physician.


THERAPEUTIC CLASS

Combined cough expectorants


STORAGE CONDITIONS

Store at a temperature not exceeding 30° C in a dry place. Protect from light & moisture. Keep out of the reach of children.

⚠ Disclaimer

The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines

allsomadhan logo

N:B-All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines"

Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved

DBID

Registration ID: 176322642

Trade License: TRAD/DNCC/040904/2023

Payment Methods
google play storeapple store
Chat with us